4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow orteronel: new trials by email Literature Review of orteronel trials Research Report on orteronel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study. Orteronel 300mg BID - Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors | Phase 2 | Terminated | Grupo Español de Tumores Huérfanos e Infrecuentes | 10 | 2014-06-01 | 2018-03-05 |
| Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer orteronel, laboratory biomarker analysis - Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer | Phase 2 | Terminated | University of Southern California | 4 | 2013-10-25 | 2017-08-31 |
| NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis TAK-700, Fluorine F 18 Sodium Fluoride, Positron Emission Tomography - Prostatic Neoplasms, Prostate Cancer | Phase 2 | Terminated | University of Wisconsin, Madison | 8 | 2013-05-01 | 2019-12-09 |
| A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone TAK-700 and LHRH agonist, prostatectomy - Prostate Cancer | Phase 2 | Terminated | Centre of Experimental Medicine | 16 | 2013-02-18 | 2017-07-07 |
Prostatic Neoplasms (3) · Granulosa Cell Tumor (1) · Neoplasm Metastasis (1)
Centre of Experimental Medicine (1) · Grupo Español de Tumores Huérfanos e Infrecuentes (1) · University of Southern California (1) · University of Wisconsin, Madison (1)
United States (2) · Spain (1) · United Kingdom (1)
Alicia Hurtado, MD (1) · Ana Santaballa, MD (1) · Isabel Bover, MD (1) · Juan Cueva, MD (1) · Justine Y Bruce, MD (1) · Laia Garrigos, MD (1) · Mitchell Gross (1) · Nuria Lainez, MD (1)
P30CA014089 (1)